-
membranes. The AEMFC technology is still under development and more research is needed on components, cell design and optimized operation conditions. The purpose of this project is to develop new PGM-free
-
technologies for the platform. In addition to self-designed phage display libraries (scFv and Fab), we are currently developing an antibody library based on a so-called single domain concept and we expect
-
technologies for the platform. In addition to self-designed phage display libraries (scFv and Fab), we are currently developing an antibody library based on a so-called single domain concept and we expect
-
responsibility will be to deliver characterized antibodies and derivatives thereof to projects within the platform and to develop tailored technologies for the platform. In addition to self-designed phage display